Krystal Biotech, Inc. (KRYS)
USD 156.64
(-7.34%)
USD 156.64
(-7.34%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 50.69 Million | - | - | - | - | 1.02 Million |
| Cost of Revenue | 3.09 Million | 4.05 Million | 2.76 Million | 1.85 Million | 974 Thousand | 141 Thousand |
| Gross Profit | 47.6 Million | -4.05 Million | -2.76 Million | -1.85 Million | -974 Thousand | 886 Thousand |
| Operating Expenses | 160.42 Million | 120.19 Million | 68.27 Million | 32.99 Million | 22.08 Million | 11.91 Million |
| Selling, General and Administrative Expenses | 98.4 Million | 77.73 Million | 40.39 Million | 15.06 Million | 6.46 Million | 4.15 Million |
| Research and Development Expenses | 46.43 Million | 42.46 Million | 27.88 Million | 17.93 Million | 15.61 Million | 7.76 Million |
| Other Expenses | 12.5 Million | 25 Million | - | - | - | - |
| Cost and Expenses | 160.42 Million | 120.19 Million | 68.27 Million | 32.99 Million | 22.08 Million | 11.91 Million |
| Operating Income | -109.72 Million | -145.19 Million | -68.27 Million | -32.99 Million | -22.08 Million | -11.91 Million |
| Interest Expense | - | 5.22 Million | 1.49 Million | - | - | 1.02 Million |
| Income Tax Expense | 1.96 Million | 34.04 Million | 2.72 Million | 1.64 Million | 576.14 Thousand | -20.14 Thousand |
| Earnings before Tax | 12.89 Million | -139.97 Million | -69.57 Million | -32.16 Million | -19.08 Million | -10.88 Million |
| Net Income | 10.93 Million | -139.97 Million | -69.57 Million | -32.16 Million | -19.08 Million | -10.88 Million |
| Earnings Per Share Basic | 0.40 | -5.49 | -3.13 | -1.71 | -1.20 | -0.97 |
| Earnings Per Share Diluted | 0.39 | -5.49 | -3.13 | -1.71 | -1.20 | -0.97 |
| Weighted Average Shares Outstanding | 27.15 Million | 25.49 Million | 22.19 Million | 18.78 Million | 15.9 Million | 11.2 Million |
| Weighted Average Shares Outstanding (Diluted) | 27.75 Million | 25.49 Million | 22.19 Million | 18.78 Million | 15.9 Million | 11.2 Million |
| Gross Margin | 0.94 | - | - | - | - | 0.86 |
| EBIT Margin | 0.35 | - | - | - | - | -11.47 |
| Profit Margin | 0.22 | - | - | - | - | -10.60 |
| EBITDA | 17.9 Million | -145.19 Million | -65.3 Million | -30.31 Million | -18.11 Million | -10.74 Million |
| Earnings Before Tax Margin | -2.16 | - | - | - | - | -11.60 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 83.84 Million | 70.28 Million | 45.25 Million | 50.69 Million | 42.14 Million | 8.55 Million |
| Cost of Revenue | 8.17 Million | 7.99 Million | 2.41 Million | 8.1 Million | 4.37 Million | 223 Thousand |
| Gross Profit | 75.66 Million | 62.28 Million | 42.83 Million | 42.59 Million | 37.76 Million | 8.33 Million |
| Operating Expenses | 61.4 Million | 41.22 Million | 37.01 Million | 139.82 Million | 34.62 Million | 34.54 Million |
| Selling, General and Administrative Expenses | 28.71 Million | 25.64 Million | 26.05 Million | - | 23.25 Million | 23.69 Million |
| Research and Development Expenses | 13.51 Million | 15.58 Million | 10.95 Million | - | 11.37 Million | 10.62 Million |
| Other Expenses | 19.18 Million | 18.5 Million | 14.91 Million | 15.59 Million | 2.87 Million | 223 Thousand |
| Cost and Expenses | 61.4 Million | 49.21 Million | 39.43 Million | 147.92 Million | 39 Million | 34.54 Million |
| Operating Income | 22.43 Million | 21.06 Million | -6.68 Million | -97.22 Million | 3.13 Million | -25.99 Million |
| Interest Expense | - | - | - | - | -25 Million | - |
| Income Tax Expense | -2.58 Million | 477 Thousand | 4.88 Million | 1.96 Million | 1.96 Million | -826 Thousand |
| Earnings before Tax | 29.76 Million | 16.04 Million | 932 Thousand | 12.89 Million | 10.65 Million | 80.74 Million |
| Net Income | 27.18 Million | 15.56 Million | 932 Thousand | 10.93 Million | 8.69 Million | 80.74 Million |
| Earnings Per Share Basic | 0.95 | 0.54 | 0.03 | - | 0.31 | 2.88 |
| Earnings Per Share Diluted | 0.91 | 0.53 | 0.03 | - | 0.30 | 2.79 |
| Weighted Average Shares Outstanding | 28.71 Million | 28.59 Million | 28.29 Million | 27.15 Million | 28.16 Million | 28.04 Million |
| Weighted Average Shares Outstanding (Diluted) | 29.9 Million | 29.63 Million | 29.29 Million | 27.75 Million | 28.81 Million | 28.89 Million |
| Gross Margin | 0.90 | 0.89 | 0.95 | 0.84 | 0.90 | 0.97 |
| EBIT Margin | 0.27 | 0.33 | 0.44 | - | 0.11 | -3.04 |
| Profit Margin | 0.32 | 0.22 | 0.02 | 0.22 | 0.21 | 9.44 |
| EBITDA | 22.43 Million | 23.05 Million | 19.92 Million | - | 4.64 Million | -25.99 Million |
| Earnings Before Tax Margin | 0.27 | 0.30 | -0.15 | -1.92 | 0.07 | -3.04 |
SAPPL
KAYNES
9788
7931
8029
NNAG